Pricing Log in Create free account

BioCardia, Inc. (BCDA) vs RVL Pharmaceuticals PLC (RVLP)

BioCardia, Inc. and RVL Pharmaceuticals PLC are both Biotechnology companies. BioCardia, Inc. and RVL Pharmaceuticals PLC are of similar size ($14.2M and $14.1M). RVL Pharmaceuticals PLC grew revenue faster over the last twelve months: 5.64% against 0.71%. BioCardia, Inc. has the higher net margin (0.00% vs −184.9%) and the higher return on invested capital (0.00% vs −80.5%). Across the 16 metrics below, BioCardia, Inc. leads on 9 and RVL Pharmaceuticals PLC on 7.

Valuation

Metric BCDA RVLP Biotechnology median
P/E n/m n/m 8.50
P/S 25.99 n/m 9.71
P/B 4.12 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 30.15 1.05 9.21
Earnings yield (69.57%) 0.00% (33.15%)
Free cash flow yield (68.06%) 0.00% (25.50%)

Profitability

Metric BCDA RVLP Biotechnology median
Gross margin 100.00% 74.73% 65.16%
Operating margin 0.00% (191.72%) 0.00%
Net margin 0.00% (184.91%) 0.00%
Free cash flow margin 0.00% (128.42%) 0.00%
Return on equity (1,803.19%) (182.44%) (56.36%)
Return on assets (214.47%) (64.94%) (48.04%)
Return on invested capital 0.00% (80.54%) 0.00%

Growth

Metric BCDA RVLP Biotechnology median
Revenue growth (TTM) 0.71% 5.64% 6.02%
EPS growth (last fiscal year) 57.59% 39.58% 30.26%
Revenue growth, 5-year CAGR 26.89% (27.35%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCDA RVLP Biotechnology median
Debt to equity 0.00 3.54 0.00
Current ratio 2.09 0.38 4.72
Net debt to EBITDA 0.30 (0.29) 0.96

Dividend

Metric BCDA RVLP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BCDA RVLP Biotechnology median
Market cap 14.21m 14.08m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack